An “intelligent tattoo” to detect skin cancer before it appears
en-GBde-DEes-ESfr-FR

An “intelligent tattoo” to detect skin cancer before it appears


Detecting melanoma before it becomes visible is a major challenge in dermatology. Now, with researchers from Université de Montréal, scientists at Université du Québec's Institut national de la recherche scientifique (INRS) have developed a promising solution.

Called SMEAR-ULM, it's a high-tech system that can detect skin cancers at their earliest stages by measuring tiny temperature variations at the surface of the skin. Led by INRS professor Jinyang Liang, the research team's findings are published in Nature Sensors.

The work was carried out in close collaboration with several research teams, including ones led by INRS professor Fiorenzo Vetrone and, at UdeM, pharmacology professor David Brambilla and medical professor Sylvain Meloche.

The potential impact of the work is significant, the scientists say.

Cases on the rise

Melanoma incidence continues to rise in Canada, and early diagnosis is critical to improving survival rates. Current diagnostic approaches rely on visual examination followed by biopsies—procedures that are invasive and sometimes unnecessary.

By enabling rapid, direct, and non-invasive assessment of suspicious skin lesions, this technology could reduce unnecessary biopsies, improve early diagnostic accuracy, and support clinical decision-making.

“Our goal is to provide a minimally invasive tool to detect very small, but still aggressive melanomas," said Liang, the study's senior author, who specializes in ultrafast imaging and biophotonics at INRS.

"Because of their small size, (the melanomas) are usually excluded from clinical visual inspection, which leaves the threat unwatched. We want to detect them, so that intervention can be made as soon as possible,”

"Even though this study was conducted in mice, this animal model replicates the genetic changes observed in human melanomas and could therefore potentially benefit patients," added Meloche, a researcher at UdeM's Institute for Research in Immunology and Cancer and co-principal author of the study.

The approach also redefines the role of temperature in cancer detection. While tumours are known to generate more heat due to their higher metabolic activity, this signal has traditionally been too imprecise to use as a diagnostic marker. SMEAR-ULM changes that by turning subtle thermal variations into a highly sensitive and measurable signal.

A temporary “tattoo”

At the core of the system is a patch of painless microneedles that deposits specialized nanoparticles just beneath the skin. These nanoparticles form a temporary “intelligent tattoo” that behaves like an array of microscopic thermometers.

When illuminated with near-infrared light, the nanoparticles emit visible light. Crucially, the lifetime of this light emission—how long it lasts—depends directly on local temperature. Because cancer cells consume more oxygen and nutrients than healthy cells, they produce additional heat, which can be detected through this optical signal.

Using an ultrafast imaging system, SMEAR-ULM captures all this information in a single high-speed snapshot, generating a detailed thermal map with submillimeter spatial resolution and sub-degree temperature sensitivity.

“We capture all the necessary information for an instantaneous temperature map in a single shot, which makes the method fast and robust to continuously monitor abnormal thermal responses in small melanomas—even within complex in vivo conditions,” said INRS graduate student Yingming Lai, the study's first author.

Only four days old

With this approach, the researchers successfully detected micro‑melanomas as early as four days old—a stage at which they are typically far too small to be identified by conventional imaging techniques.

Conversely, conventional thermal imaging methods rely on infrared technologies that suffer from limited spatial resolution and high noise levels. As a result, they usually only detect tumours larger than 5 millimeters—lesions already visible to the naked eye.

As well, existing microneedle-based sensing approaches require repeated measurements, limiting their use in living subjects.

The SMEAR-ULM technology overcomes these limitations by combining microneedle encoding, rare-earth-doped nanoparticles, and ultrafast optical imaging into a system capable of real-time, single-shot thermal mapping in vivo.

This breakthrough effectively transforms skin temperature from a secondary indicator into a precise diagnostic biomarker for early-stage melanoma, the researchers say.

Beyond skin cancer detection, their platform could be adapted to map other physiological parameters—such as pH or ion concentrations—opening new possibilities in biomedical imaging and diagnostics.

«Single-shot microneedle-encoded upconversion lifetime mapping for real-time in vivo thermo-dermoscopy», by Yingming Lai et al., was published May 20 2026 in Nature Sensors.

This research was made possible through the support of several funding agencies and partners, including the Natural Sciences and Engineering Research Council of Canada (NSERC), the Canada Research Chairs Program, the Canadian Cancer Society, the New Frontiers in Research Fund, the Fonds de recherche du Québec – Nature et technologies and Santé, the Canadian Institutes of Health Research (CIHR), as well as the Faculty of Pharmacy at Université de Montréal. The project also benefited from the support of the Canadian Generic Pharmaceutical Association and Biosimilars Canada.
Regions: North America, Canada
Keywords: Health, Medical, Applied science, Nanotechnology

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Témoignages

We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet
AlphaGalileo is a great source of global research news. I use it regularly.
Robert Lee Hotz, LA Times

Nous travaillons en étroite collaboration avec...


  • The Research Council of Norway
  • SciDevNet
  • Swiss National Science Foundation
  • iesResearch
Copyright 2026 by DNN Corp Terms Of Use Privacy Statement